address1,address2,city,zip,country,phone,fax,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,shortName,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,regularMarketChangePercent,regularMarketPrice,marketState,longName,trailingPegRatio
"125, Kandivli Industrial Estate",Kandivli (West),Mumbai,400067,India,91 22 6210 5000,91 22 6210 5005,https://www.ipca.com,Drug Manufacturers - Specialty & Generic,drug-manufacturers-specialty-generic,Drug Manufacturers - Specialty & Generic,Healthcare,healthcare,Healthcare,"Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, hematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India.","[{'maxAge': 1, 'name': 'Mr. Premchand  Godha A.C. A., B. Com., CA', 'age': 78, 'title': 'Executive Chairman', 'yearBorn': 1946, 'fiscalYear': 2024, 'totalPay': 123004419, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Pranay Premchand Godha', 'age': 52, 'title': 'CEO, MD & Executive Director', 'yearBorn': 1972, 'fiscalYear': 2024, 'totalPay': 65228222, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ajit Kumar Bhanwarlal Jain A.C.A., B.Sc.', 'age': 69, 'title': 'CFO, MD & Executive Director', 'yearBorn': 1955, 'fiscalYear': 2024, 'totalPay': 84436790, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Harish Pandurang Kamath', 'age': 65, 'title': 'Compliance Officer, Corporate Counsel & Company Secretary', 'yearBorn': 1959, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Prashant Premchand Godha', 'age': 49, 'title': 'Executive Director', 'yearBorn': 1975, 'fiscalYear': 2024, 'totalPay': 69755704, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Pawan  Kothari', 'age': 59, 'title': 'Vice President of Operations', 'yearBorn': 1965, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Vishnu Saran Singh Kushwaha', 'age': 56, 'title': 'Vice President of Technical', 'yearBorn': 1968, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Sunil  Ghai', 'age': 61, 'title': 'President of Marketing', 'yearBorn': 1963, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Saidutta  Nanda', 'title': 'President of Human Resources', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Ashok  Kumar', 'age': 70, 'title': 'President of R&D - Chemicals', 'yearBorn': 1954, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",1735603200,[],86400,2,1362.2,1364.5,1329.0,1426.9,1362.2,1364.5,1329.0,1426.9,4.0,0.29,1754265600,0.1376,0.38,0.236,46.68735,28.305122,474603,474603,276818,278206,278206,0.0,0.0,0,0,343616716800,1052.0,1755.9,3.8437638,1399.472,1484.5398,4.0,0.0029364266,INR,False,362958389248,0.08252,139561875,253704000,0.45049998,0.43129003,254274000,273.553,4.951143,1743379200,1774915200,1743379200,0.138,7376799744,29.01,47.85,2:1,1641772800,4.06,21.027,0.19869769,0.094471335,2.0,1754265600,EQUITY,1354.4,1918.0,900.0,1540.6666,1590.0,2.3,buy,21,11076200448,43.606,17261400064,13627400192,1.249,2.627,89395896320,16.246,352.407,0.07263,0.097449996,61610401792,51487500,13213200384,0.136,0.105,0.68919,0.19309,0.14632,INR,IPCALAB.NS,en-US,US,Equity,Delayed Quote,True,HIGH,IPCA LABORATORIES LTD,[],1750413600,NSI,finmb_4481217,Asia/Kolkata,IST,19800000,in_market,False,False,820467900000,-7.7999268,1329.0 - 1426.9,NSE,276818,302.40002,0.2874525,1052.0 - 1755.9,-401.5,-0.22865766,19.869768,1748516340,1754909940,1755259200,1748599200,1748599200,True,29.01,47.85,43.87942,30.866405,-45.07202,-0.032206446,-130.13977,-0.087663375,15,15,2.3 - Buy,False,-0.5725978,1354.4,POSTPOST,Ipca Laboratories Limited,
